The largest database of trusted experimental protocols

25 protocols using stbl3 e coli

1

SCA17 Allele Expansion Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spinocerebellar ataxia type 17 allele CAG/CAA-repeat tracts from 30 patients from this cohort were PCR amplified using Phusion High-Fidelity DNA polymerase (New England Biolabs) and primers which flank the CAG/CAA-repeat region and introduce restriction enzyme cleavage sites. The primers used were TBPx3 BamHI Forward (5′-ATGTTTggatccTCCACAGGGTGCCATGAC-3′) and TBPx3 XhoI Reverse (5′-GGTTTGctcgagACACGAAGTACTCACTGC-3′), with restriction sites indicated in lower case. The PCR reactions were processed and cloned into a pcDNA3.1(+) vector similar to previously described for SCA1 alleles (Menon et al., 2013 (link)) or pCR-Blunt using the Zero Blunt PCR Cloning Kit (Thermo Fisher Scientific). Clone plasmids were propagated in Stbl3 E. coli (Thermo Fisher Scientific) (genotype FmcrB mrr hsdS20(rB, mB) recA13 supE44 ara-14 galK2 lacY1 proA2 rpsL20(StrR) xyl-5 λleumtl-1). Plasmids were sequenced using the BigDye Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific).
+ Open protocol
+ Expand
2

Recombinant ALKBH5 Plasmid Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wild type ALKBH5-CDS and mutant ALKBH5-CDS were PCR-amplified from pF RT/TO/HIS/FLAG/HA-ALKBH5 plasmid (38073, addgene) and pFLAG CMV5.1-ABH 5-H204A (kindly provided by Dr. Chuan He), and then cloned into the pCDH lentivir al vector (CD513B-1, SBI, Mountain View, CA) using XbaI and BamHI enzyme sites. The TRC shRNAs targeting human ALKBH5 (shA5-#1: TRCN0000291838; shA5-#2: TRCN0000291769), mouse Alkbh5 (shA5-#a: TRCN0000201776; shA5-#b: TRCN00001 92524) were purchased from Sigma-Aldrich, the non-targeting control (pLKO.1) was fr om addgene. The inducible shRNA plasmids (TRIPZ-shA5-#3: V2THS_173653; TRIPZ-shA5-#4: V2THS_173654), as well as the non-targeting control shRNA, were all purchased from GE Dharmacon. The Lenti-iCas9-neo (doxycycline-inducible Cas9-EGFP ve ctor) and lenti-guide (gRNA expression vector) were purchased from Addgene. Lenti-s gALKBH5 was constructed as previously described (Ran et al., 2013 (link)). Stbl3™ E.coli (C7373–03, Thermo Fisher Scientific) and 5-alpha Competent E. coli (C29871, New E ngland Biolabs) were used in transformation.
+ Open protocol
+ Expand
3

Isolation of pUC19 Plasmid DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA solutions were prepared from Stbl3 E. coli (ThermoFisher, Waltham, MA) transformed with the pUC19 plasmid. Bacteria were grown in an incubator at 37C for two days in LB Broth containing 100μM ampicillin prior to harvesting and centrifugation. The resulting bacteria were then lysed and DNA was isolated using a DNEasy Blood and Tissue Kit (Qiagen). DNA samples were analysed using a NanoDrop (Thermo Scientific) to determine concentration and verify purity.
+ Open protocol
+ Expand
4

CRISPR-Cas9 sgRNA Design and Lentiviral Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three sgRNA sequences targeting Napa (5′-CTTGAACATGTTCGCCGCTC-3′, 5′-AGATTGCTCATAGTGGGCGA-3′, 5′-TGCTGGGAACGCTTTCTGCC-3′) and Ppp2cb (5′-TCTCGCACAGCGTCCGCACT-3′, 5′-ATACGAACTACCTATTCATG-3′, 5′- CGCAATATTGTGATGCGCTC-3′) were designed using CHOPCHOP (version 3) [21 (link)]. Custom oligos (Integrated DNA Technologies, Coralville, IA, USA) were phosphorylated in vitro with T4 polynucleotide kinase (New England Biolabs, Ipswich, MA, USA), annealed by heating/cooling in a thermocycler, ligated into the BsmBI site of pSECC (Addgene # 60820) with T4 DNA Ligase (New England Biolabs, Ipswich, MA, USA), and plasmid was purified from Stbl3 E. coli (Thermofisher, Waltham, MA, USA). Lentiviral particles for each individual sgRNA construct and a scrambled control (5′-GCGAGGTATTCGGCTCCGCG-3′) [22 (link)] were generated by Lipofectamine Plus/LTX-mediated transfection of 293FT cells with pSECC, pCMV-VSV-G (Addgene #8454), pMDLg/pRRE (Addgene #12251), and pRSV-Rev (Addgene #12253). The supernatant containing viral particles was collected at 48 h post-transfection.
+ Open protocol
+ Expand
5

HIV Virus Production and Immune Cell Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Both cell lines (HEK293T/17 cells) and primary human immune cells were used to make stocks of infectious HIV virus and create target/effectors cells for co-culture assays. For all primary human samples, peripheral blood mononuclear cells (PBMCs) were collected by Ficoll gradient separations from buffy coat samples, cryopreserved and stored at −150°C for future use. All HIV and CAR T cell plasmids were grown up in Stbl3 E.coli (ThermoFisher, Cat#C737303).
+ Open protocol
+ Expand
6

Generation and Validation of IL-10RA Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
pcDNA3.1( +) vector coding for wild-type or mutant IL-10RA were purchased from GenScript and expanded in Stbl3 E. coli (Thermo Fisher) according to standard protocols. Plasmids were purified using the E.Z.N.A.® Endo-Free Plasmid Maini Kit (Omega bio-tek). Following expansion in bacterial cultures and plasmid purification, all IL-10RA sequences were re-validated by Sanger sequencing (Source BioScience) to exclude mutagenesis during propagation.
+ Open protocol
+ Expand
7

CRISPRi Guide RNA Cloning and Lentivirus Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Guide RNAs for CRISPRi experiments were chosen from (Horlbeck et al. 2016 (link)). Guides were cloned into the LRG2.1 mCherry vector (Addgene; Cat. No. 108099) using a BsmBI digestion as previously described (Giuliano et al. 2019 ). Plasmids were transformed in Stbl3 E. coli (Thermo Fisher; Cat. No. C737303) and sequenced to confirm the presence of the correct gRNA sequence. A dCas9-KRAB construct (Addgene; Cat. No. 85969) was used to knock down target gene expression. Guide RNA sequences are listed in Table S1B.
Lentivirus was generated using calcium phosphate transfection as previously described (Chang et al. 2013 (link)). Supernatant was harvested at 2 to 3 intervals 48 to 72 hr post-transfection by filtering through a 0.45 μm syringe, and then frozen at −80° C for later use or supplied directly to cells with 4 μg/mL polybrene.
+ Open protocol
+ Expand
8

HIV Variant Plasmid Construction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids encoding HIV variants were constructed by inducing the mutations on pNL4.3 [26 (link)] (the plasmid was obtained from M. Martin through the AIDS Research and Reference Reagent Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health) using the QuickChange Lightning kit (Agilent Technologies, Santa Clara, CA, USA) with mutagenesis primers (Table S2) as previously described [16 (link)]. Mutagenesis was confirmed by Sanger DNA sequencing using the BigDye terminator v.3 (Thermo Fisher) with SeqStudio Genetic Analyzer (Thermo Fisher), and plasmids were maintained in Stbl3 E. coli (Thermo Fisher). The plasmid purification was carried out using the EndoFree Plasmid Maxi Kit (Qiagen).
+ Open protocol
+ Expand
9

CRISPR Plasmid Generation for Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Guide RNAs for CRISPR experiments were designed with Benchling (www.benchling.com). Guides were cloned into the Lenti-Cas9-gRNA-GFP vector (Addgene #124770) or LRCherry2.1 (Addgene #108099) using a BsmBI digestion as previously described96 (link). Plasmids were transformed in Stbl3 E. coli (Thermo Fisher Scientific, cat. no. C737303) and sequence-verified to confirm the presence of the correct gRNA. CRISPR gRNA sequences are listed in Table S5A.
+ Open protocol
+ Expand
10

Construction of HIV Variant Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids encoding HIV variants were constructed by site-directed mutagenesis on pNL4.3 [33 (link)] (the plasmid was obtained from M. Martin through the AIDS Research and Reference Reagent Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health). Site-directed mutagenesis was performed using a QuickChange Lightning kit (Agilent Technologies, Santa Clara, CA, USA) with mutagenesis primers (Table S1), as previously described [22 (link)]. RH- or IN-deleted constructs were created by inverting PCR using Pfu II Taq polymerase (Agilent Technology) with deletion primers (Table S1). Mutagenesis was confirmed by Sanger DNA sequencing using the BigDye terminator v.3 (Thermo Fisher) with SeqStudio Genetic Analyzer (Thermo Fisher), and the plasmids were maintained in Stbl3 E. coli (Thermo Fisher). The plasmid purification was carried out using the EndoFree Plasmid Maxi Kit (Qiagen, Germantown, MD, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!